|
ZNF16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.806410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.385600E-01 |
| Normal-vs-Stage2 |
7.859800E-01 |
| Normal-vs-Stage3 |
9.977700E-02 |
| Normal-vs-Stage4 |
8.718100E-02 |
| Stage1-vs-Stage2 |
5.612800E-01 |
| Stage1-vs-Stage3 |
3.851000E-01 |
| Stage1-vs-Stage4 |
3.191200E-01 |
| Stage2-vs-Stage3 |
3.086800E-01 |
| Stage2-vs-Stage4 |
2.384400E-01 |
| Stage3-vs-Stage4 |
7.564800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.524020E-01 |
| Normal-vs-AfricanAmerican |
9.618800E-01 |
| Normal-vs-Asian |
6.660600E-01 |
| Caucasian-vs-AfricanAmerican |
3.362200E-01 |
| Caucasian-vs-Asian |
2.714600E-01 |
| AfricanAmerican-vs-Asian |
7.872400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.591800E-01 |
| Normal-vs-Female |
1.559590E-01 |
| Male-vs-Female |
5.958200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.572650E-01 |
| Normal-vs-Age(41-60Yrs) |
3.516400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.178800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.856800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.971600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.763600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.714200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.646200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.225400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.174800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.901900E-02 |
| Classical-VS-Follicular |
3.342600E-01 |
| Classical-VS-Other |
8.047200E-01 |
| Classical-VS-Normal |
4.456600E-01 |
| Tall-VS-Follicular |
1.991400E-01 |
| Tall-VS-Other |
4.110400E-01 |
| Tall-VS-Normal |
2.782100E-02 |
| Follicular-VS-Other |
9.135600E-01 |
| Follicular-VS-Normal |
2.277400E-01 |
| Other-VS-Normal |
6.384400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.940800E-01 |
| Normal-vs-N1 |
2.627900E-02 |
| N0-vs-N1 |
7.788100E-02 |
|
|
